Summary & Overview
HCPCS Level II J3105: Terbutaline Sulfate Injection, Up to 1 mg
HCPCS Level II code J3105 designates an injection of terbutaline sulfate, up to 1 mg. This code captures a single therapeutic administration of a bronchodilator commonly used to treat acute bronchospasm. As an HCPCS Level II code for a drug injection, J3105 is relevant across ambulatory clinics, emergency departments, and inpatient settings where parenteral bronchodilator therapy is provided. Nationally, accurate coding of medication injections supports appropriate payment, clinical documentation, and pharmacologic utilization tracking.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code denotes, the clinical contexts in which terbutaline injection is used, and the service settings where billing typically occurs. The publication outlines common modifiers and ancillary billing considerations, notes related code families when available, and identifies areas where input data was not provided.
This summary equips billing managers, clinical coders, and policy analysts with a practical overview of HCPCS Level II code J3105, clarifying its clinical purpose and where it fits into drug administration billing workflows. Data not available in the input is indicated where applicable.
Billing Code Overview
HCPCS Level II code J3105 represents an injection of terbutaline sulfate, up to 1 mg. The service described is a single-dose therapeutic injection of a bronchodilator medication used for acute reversible airway constriction.
-
Service type: Therapeutic injection/medication administration
-
Typical site of service: Ambulatory clinic, emergency department, or inpatient setting where injectable bronchodilator therapy is administered
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 28-year-old female presents to the outpatient obstetrics triage unit at 32 weeks gestation with regular uterine contractions and cervical change consistent with preterm labor. Maternal vital signs are stable; fetal heart tracing is reassuring. The treating clinician orders a single subcutaneous or intramuscular dose of terbutaline sulfate to suppress uterine contractions as a tocolytic while additional evaluation and transfer arrangements are completed. The medication is prepared and administered by a credentialed nurse or obstetrician in the clinic or emergency department. Typical documentation includes indication (preterm labor), time and route of administration, dose (up to 1 mg per J3105), patient response, maternal and fetal monitoring during and after administration, and any adverse effects (tachycardia, tremor, hypotension). Billing uses HCPCS Level II code J3105 with an appropriate modifier to reflect service circumstances, and the encounter links to the maternal-fetal diagnosis code(s) supporting medical necessity.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when administration required substantially greater resources or atypical complexity (document rationale). |